<table border="1"><tr><th>Trade names</th><td>Levaquin, Tavanic,Leflox, Levobact, Iquix, others</td></tr><tr><th>AHFS/Drugs.com</th><td>Monograph</td></tr><tr><th>MedlinePlus</th><td>a697040</td></tr><tr><th>License data</th><td>EU |  EMA | by INN | US |  DailyMed | Levofloxacin | US | FDA: Levofloxacin</td></tr><tr><th>Routes of | administration</th><td>By mouth, intravenous (IV), eye drops</td></tr><tr><th>Drug class</th><td>Fluoroquinolone</td></tr><tr><th>ATC code</th><td>J01MA12 ( | WHO | ) S01AE05 ( | WHO | ) A02BD10 ( | WHO | ) J01RA05 ( | WHO | )</td></tr><tr><th>Legal status</th><td>US |  ℞-only | EU |  Rx-only | In general: ℞ (Prescription only)</td></tr><tr><th>Bioavailability</th><td>99%</td></tr><tr><th>Protein binding</th><td>31%</td></tr><tr><th>Metabolism</th><td>&lt;5% desmethyl and N-oxide metabolites</td></tr><tr><th>Elimination | half-life</th><td>6.9 hours</td></tr><tr><th>Excretion</th><td>Kidney, mostly unchanged (83%)</td></tr><tr><th>Identifiers</th><td>IUPAC name | ( | S | )-9-fluoro-2,3-dihydro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-7 | H | -pyrido[ | 1 | , | 2 | , | 3 | - | de | ]-1,4-benzoxazine-6-carboxylic acid</td></tr><tr><th>CAS Number</th><td>100986-85-4</td></tr><tr><th>PubChem | CID</th><td>149096</td></tr><tr><th>DrugBank</th><td>DB01137</td></tr><tr><th>ChemSpider</th><td>131410</td></tr><tr><th>UNII</th><td>RIX4E89Y14</td></tr><tr><th>KEGG</th><td>D08120 | C07660</td></tr><tr><th>ChEBI</th><td>CHEBI:63598</td></tr><tr><th>ChEMBL</th><td>ChEMBL33</td></tr><tr><th>NIAID ChemDB</th><td>002307</td></tr><tr><th>PDB ligand</th><td>LFX ( | PDBe | , | RCSB PDB | )</td></tr><tr><th>CompTox Dashboard | ( | EPA | )</th><td>DTXSID0041060</td></tr><tr><th>ECHA InfoCard</th><td>100.115.581</td></tr><tr><th>Formula</th><td>C | 18 | H | 20 | F | N | 3 | O | 4</td></tr><tr><th>Molar mass</th><td>361.373 |  g·mol | −1</td></tr><tr><th>3D model (JSmol)</th><td>Interactive image</td></tr><tr><th>Density</th><td>1.5±0.1 g/cm | 3</td></tr></table>